AURX insiders were on both sides of the trade this year. Buys came to roughly $9,547 (one buyer), sales to $300,000 (one seller).
The largest purchase came from JORDEN DAVID EMERSON (CEO), about $8,703. That includes C-suite money, which tends to get the most attention.
Big money check: 1 institutions held AURX as of Q2 2026, and funds were split between buying and selling. Last full quarter: net buying by insiders. Insiders bought in 2 of the last 7 full quarters.
| Filed | Insider | Role | Type | Shares | Price | Value | Source |
|---|---|---|---|---|---|---|---|
| Aug 31, 2026 | JORDEN DAVID EMERSON | CEO | Buy | 789 | $1.07 | $844 | SEC |
| Aug 31, 2026 | JORDEN DAVID EMERSON | CEO | Buy | 7,984 | $1.09 | $9K | SEC |
| Dec 3, 2025 | JORDEN DAVID EMERSON | CEO | Sell | 200,000 | $1.50 | $300K | SEC |
| Aug 1, 2025 | SHEEDY CHARLES E | 10% Owner | Buy | 133,333 | $1.50 | $200K | SEC |
| Sep 19, 2024 | SHEEDY CHARLES E | 10% Owner | Buy | 125,000 | $0.75 | $94K | SEC |
| May 21, 2024 | SHEEDY CHARLES E | 10% Owner | Buy | 100,000 | $0.75 | $75K | SEC |
| Dec 20, 2023 | SHEEDY CHARLES E | 10% Owner | Buy | 150,000 | $0.50 | $75K | SEC |
| Aug 4, 2023 | SHEEDY CHARLES E | 10% Owner | Buy | 62,500 | $2.00 | $125K | SEC |
In the last 12 months Nuo Therapeutics, Inc. insiders made open-market purchases worth about $9,547 and sales worth about $300,000. Data comes from SEC Form 4 filings, updated every 30 minutes on CapitalSnitch.
The most recent open-market insider trade in AURX was filed on 2026-08-31.
1 investment managers reported holding AURX in SEC Form 13F filings for Q2 2026.
No congressional trades in AURX were reported in the past two years. The full list is free on CapitalSnitch.
Public-record data for research and education, not investment advice. Insider sales are often pre-planned (10b5-1). Congress data: Data derived from public disclosures filed under the Ethics in Government Act and the STOCK Act, republished free for public transparency and news reporting. Disclosures may lag the trade by 45 days or more and show amounts only as ranges. This data may not be used for credit rating, loan underwriting, solicitation of money (political, charitable or other), direct-mail or commercial targeting (5 U.S.C. 13107).